Sonoma Pharmaceuticals
SNOA
#11038
Rank
S$7.1 M
Marketcap
S$1.40
Share price
-6.84%
Change (1 day)
-70.13%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -S$1.81 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are S$21.92 Million. In 2025 the company made an earning of -S$3.57 Million, an increase over its 2024 earnings that were of -S$5.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$1.81 Million-49.26%
2025 -S$3.57 Million-38.02%
2024 -S$5.75 Million0.54%
2023 -S$5.72 Million-31.5%
2022 -S$8.35 Million16.86%
2021 -S$7.15 Million194.32%
2020 -S$2.43 Million-58.76%
2019 -S$5.89 Million-65.66%
2018 -S$17.14 Million4.84%
2017 -S$16.35 Million-2.17%
2016 -S$16.71 Million32.12%
2015 -S$12.65 Million-307.74%
2014 S$6.08 M-197.5%
2013 -S$6.25 Million
2010 -S$9.76 Million-14.02%
2009 -S$11.35 Million-57.28%
2008 -S$26.56 Million-8.03%
2007 -S$28.88 Million3.85%
2006 -S$27.81 Million39.31%
2005 -S$19.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 11,217.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.39 Million 1,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA